Table 2. Efficacy of spleen aminopeptide on liver damage.
| Variables | Total | Spleen aminopeptide | P value | |
|---|---|---|---|---|
| Without | With | |||
| Liver transaminase level (1 d before treatment) | ||||
| ALT (U/L) | 201 [142–271] | 189 [137–251] | 214 [155–323] | 0.478 |
| AST (U/L) | 139 [97–215] | 123 [89–201] | 155 [102–258] | 0.067 |
| Liver transaminase level (2 w after treatment) | ||||
| ALT (U/L) | 123 [80–161] | 125 [96–175] | 102 [58–146] | 0.001 |
| AST (U/L) | 91 [56–112] | 96 [64–110] | 76 [43–114] | 0.151 |
| Liver transaminase level (4 w after treatment) | ||||
| ALT (U/L) | 65 [42.3–103] | 72 [53–123] | 54 [37–89] | 0.003 |
| AST (U/L) | 46 [31–78] | 46 [36–86] | 44 [29–68] | 0.137 |
| Jaundice index (1 d before treatment) | ||||
| TB (ìmol/L) | 103.4 (87.6–152.8) | 123.0 (89.6–186.4) | 102.6 (80.2–140.3) | 0.137 |
| DB (ìmol/L) | 96.5 (65.4–122.2) | 102.6 (68.2–141.0) | 85.9 (65.2–106.8) | 0.103 |
| Jaundice index (2 w after treatment) | ||||
| TB (ìmol/L) | 67.2 (44.8–91.7) | 70.9 (46.4–102.2) | 60.15 (43.5–78.5) | 0.070 |
| DB (ìmol/L) | 48.2 (31.6–67.5) | 53.2 (34.2–70.4) | 40.8 (26.2–65.4) | 0.046 |
| Jaundice index (4 w after treatment) | ||||
| TB (ìmol/L) | 35.7 (23.8–57.2) | 46.1 (26.4–68.7) | 32.5 (23.5–45.5) | 0.007 |
| DB (ìmol/L) | 28.5 (18.0–39.7) | 35.7 (20.8–45.9) | 19.2 (12.8–35.7) | 0.002 |
Data are median (IQR). P values comparing with spleen aminopeptide and without spleen aminopeptide are from χ2, Fisher’s exact test, or Mann-Whitney U test.